Results 31 to 40 of about 4,196 (141)
Cirugía y Cirujanos, 2023 Objetivo: Determinar la incidencia de reacciones adversas (RA) tras la primera dosis de la vacuna Pfizer-BioNTech e identificar algunos factores asociados con ellas. Método: Se realizó un estudio de cohorte retrospectiva.
José E. López-Contreras +5 more
doaj +1 more source
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting
Journal of Medical Virology, Volume 95, Issue 2, February 2023., 2023 Abstract One of the most consequential unknowns of the COVID‐19 pandemic is the frequency at which vaccine boosting provides sufficient protection from infection. We quantified the statistical likelihood of breakthrough infections over time following different boosting schedules with messenger RNA (mRNA)‐1273 (Moderna) and BNT162b2 (Pfizer‐BioNTech ...
Jeffrey P. Townsend +2 more
wiley +1 more source
Journal of Medical Virology, Volume 95, Issue 1, January 2023., 2023 Abstract Evidence about the long‐term persistence of the booster‐mediated immunity against Omicron is mandatory for pandemic management and deployment of vaccination strategies. A total of 155 healthcare professionals (104 COVID‐19 naive and 51 with a history of SARS‐CoV‐2 infection) received a homologous BNT162b2 booster.
Julien Favresse +8 more
wiley +1 more source
Journal of Immunology Research, Volume 2023, Issue 1, 2023., 2023 January 2022 onward, India witnessed a sudden increase in Omicron COVID‐19 infections, having a mild course that prompted us to identify the key host factors/immune molecules modulating disease course/outcomes. The current study evaluated the percentages of lymphocyte subsets by flowcytometry, SARS‐CoV‐2 specific T‐cell immune response by ELISPOT ...
Pragya D. Yadav +11 more
wiley +1 more source
Frontiers in Oncology, 2023 Patients affected by myelofibrosis (MF) or polycythemia vera (PV) and treated with ruxolitinib are at high risk for severe coronavirus disease 2019. Now a vaccine against the virus SARS-CoV-2, which is responsible for this disease, is available. However,
Giuseppe A. Palumbo +11 more
doaj +1 more source
IET Nanobiotechnology, Volume 16, Issue 3, Page 67-77, May 2022., 2022 Abstract After the outbreak of coronavirus disease 2019 (COVID‐19) in December 2019 and the increasing number of SARS‐CoV‐2 infections all over the world, researchers are struggling to investigate effective therapeutic strategies for the treatment of this infection.
Seyedeh Hoda Alavizadeh +6 more
wiley +1 more source
COVID-19: Characteristics and Therapeutics
Cells, 2021 Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in December 2019 is still haunting the entire human race and has affected not only the healthcare system but also the global socioeconomic balances.
Rameswari Chilamakuri, Saurabh Agarwal
doaj +1 more source
, 2022 Broadly neutralizing ability is critical for developing the next-generation SARS-CoV-2 vaccine. We collected sera samples between December 2021-January 2022 from 113 Taiwan naïve participants after their second dose of homologous vaccine (AZD1222, mRNA ...
Chiao-Hsuan Chao (5150750) +5 more
core +1 more source
Bulletin of the National Research Centre, 2021 Background High effectiveness of COVID-19 vaccines is essential for the pandemic control. This study systematically reviewed available evidence on effectiveness of ChAdOx1 and BNT162b2 vaccines in the general population, for improved vaccine policies and
Chinonyerem O. Iheanacho +2 more
doaj +1 more source
Brain and Behavior, Volume 11, Issue 8, August 2021., 2021 This paper has laid sight and yielded good data that should aid in finding correlations between healthcare profession spectrums and stress levels, as well as providing recommendations that may remarkably decrease the consequences of the pandemic on healthcare professionals and the healthcare system. Abstract Background The 2019 novel coronavirus (COVID‐
Ibrahim M. Mahgoub +6 more
wiley +1 more source